MCM
ISEE

Mazama Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Mazama Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-842
Closed -$66K – 193
2015
Q4 		$66K Buy
842
+200
+31% +$11.6K 0.01% 208
2015
Q3 		$26K Sell
642
-119
-16% -$6.3K 0.01% 235
2015
Q2 		$40K Sell
761
-386
-34% -$19.2K 0.01% 228
2015
Q1 		$53K Buy
1,147
+128
+13% +$6.64K 0.01% 212
2014
Q4 		$46K Hold
1,019
– – 0.01% 234
2014
Q3 		$40K Buy
+1,019
New +$40K 0.01% 230
2013
Q4 		– Sell
-20,000
Closed -$594K – 284
2013
Q3 		$594K Buy
+20,000
New +$567K 0.32% 109

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Mazama Capital Management's ISEE Position: Q1 2016 in Review

Mazama Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2016, closing a stake of 842 shares — an estimated $66K sold.

Mazama Capital Management first reported a position in ISEE in Q3 2013 and held it in 7 quarters. The position peaked at $594K in Q3 2013. 162 funds tracked by Wall St. Rank hold ISEE as of Q1 2016.

  • Mazama Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Mazama Capital Management sold 842 IVERIC bio, Inc. Common Stock shares in Q1 2016, an estimated $66K.
  • Mazama Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and held it in 7 quarters.
  • Mazama Capital Management's IVERIC bio, Inc. Common Stock position peaked at $594K in Q3 2013.
  • 162 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.